GL1X · GenesisL1 explorer

Research workbench

Crystal structure of BH32 alkylated with the mechanistic inhibitor 2- bromoacetophenone

Analyse Crystal structure of BH32 alkylated with the mechanistic inhibitor 2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6Q7N
Type
protein
Length
230 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
BH32
UniProt
O58216
Ligands
AC0
Pockets
1 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 54% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABH32protein23054% helix, 15% strandO58216

Ligands and binding sites

  • AC0 · 1-phenylethanone · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16110.790.8457AC0

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 6Q7N · Crystal structure of BH32 alkylated with the mechanistic inhibitor 2-bromoacetophe · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.